Filing Details
- Accession Number:
- 0001567619-21-019298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 19:13:14
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 19:13:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189140 | R John Stuelpnagel | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-11-01 | 100 | $160.33 | 361,516 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-11-01 | 100 | $160.75 | 361,416 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-11-01 | 100 | $161.52 | 361,316 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-11-01 | 1,494 | $163.10 | 359,822 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-11-01 | 2,906 | $163.89 | 356,916 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-11-01 | 300 | $164.58 | 356,616 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $162.50 to $163.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $163.50 to $164.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $164.55 to $164.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.